234 related articles for article (PubMed ID: 23734697)
1. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
Radtke J; Schmidt K; Wulff H; Köhler R; de Wit C
Br J Pharmacol; 2013 Sep; 170(2):293-303. PubMed ID: 23734697
[TBL] [Abstract][Full Text] [Related]
2. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
3. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
[TBL] [Abstract][Full Text] [Related]
4. P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.
Dominguez Rieg JA; Burt JM; Ruth P; Rieg T
Acta Physiol (Oxf); 2015 Mar; 213(3):628-41. PubMed ID: 25545736
[TBL] [Abstract][Full Text] [Related]
5. Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension.
Jobs A; Schmidt K; Schmidt VJ; Lübkemeier I; van Veen TA; Kurtz A; Willecke K; de Wit C
Hypertension; 2012 Dec; 60(6):1422-9. PubMed ID: 23090768
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
[TBL] [Abstract][Full Text] [Related]
8. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
[TBL] [Abstract][Full Text] [Related]
9. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
10. Myoendothelial coupling through Cx40 contributes to EDH-induced vasodilation in murine renal arteries: evidence from experiments and modelling.
Brasen JC; de Wit C; Sorensen CM
Acta Physiol (Oxf); 2018 Jan; 222(1):. PubMed ID: 28613412
[TBL] [Abstract][Full Text] [Related]
11. Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction.
Milkau M; Köhler R; de Wit C
FASEB J; 2010 Sep; 24(9):3572-9. PubMed ID: 20427707
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat.
Khaddaj Mallat R; Mathew John C; Mishra RC; Kendrick DJ; Braun AP
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315169
[TBL] [Abstract][Full Text] [Related]
13. Distinct endothelium-derived hyperpolarizing factors emerge in vitro and in vivo and are mediated in part via connexin 40-dependent myoendothelial coupling.
Boettcher M; de Wit C
Hypertension; 2011 Apr; 57(4):802-8. PubMed ID: 21357279
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
Mishra RC; Wulff H; Hill MA; Braun AP
J Cardiovasc Pharmacol; 2015 Jul; 66(1):118-27. PubMed ID: 25815673
[TBL] [Abstract][Full Text] [Related]
15. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of chemical coupling by an endothelial Cx40 mutant attenuates endothelium-dependent vasodilation by KCa channels and elevates blood pressure in mice.
Chaston DJ; Haddock RE; Howitt L; Morton SK; Brown RD; Matthaei KI; Hill CE
Pflugers Arch; 2015 Sep; 467(9):1997-2009. PubMed ID: 25369777
[TBL] [Abstract][Full Text] [Related]
17. SKA-31, an activator of endothelial Ca
Khaddaj-Mallat R; Mathew John C; Braun AP
Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
[TBL] [Abstract][Full Text] [Related]
18. Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed.
Oliván-Viguera A; Valero MS; Pinilla E; Amor S; García-Villalón ÁL; Coleman N; Laría C; Calvín-Tienza V; García-Otín ÁL; Fernández-Fernández JM; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Badorrey R; Simonsen U; Rivera L; Wulff H; Köhler R
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):184-92. PubMed ID: 26821335
[TBL] [Abstract][Full Text] [Related]
19. KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca
Mishra RC; Kyle BD; Kendrick DJ; Svystonyuk D; Kieser TM; Fedak PWM; Wulff H; Braun AP
Metabolism; 2021 Jan; 114():154390. PubMed ID: 33039407
[TBL] [Abstract][Full Text] [Related]
20. Loss of functional endothelial connexin40 results in exercise-induced hypertension in mice.
Morton SK; Chaston DJ; Howitt L; Heisler J; Nicholson BJ; Fairweather S; Bröer S; Ashton AW; Matthaei KI; Hill CE
Hypertension; 2015 Mar; 65(3):662-9. PubMed ID: 25547341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
